Grantham, Mayo, Van Otterloo & Co (GMO)’s Nucor NUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$43.6M Buy
257,987
+14,050
+6% +$2.45M 0.11% 80
2025
Q4
$39.8M Buy
243,937
+29,827
+14% +$4.48M 0.1% 87
2025
Q3
$29M Buy
214,110
+2,975
+1% +$421K 0.08% 127
2025
Q2
$27.4M Sell
211,135
-60,277
-22% -$7.04M 0.08% 135
2025
Q1
$32.7M Sell
271,412
-1,852
-0.7% -$239K 0.1% 130
2024
Q4
$31.9M Sell
273,264
-837
-0.3% -$120K 0.1% 128
2024
Q3
$41.2M Buy
274,101
+13,866
+5% +$2.09M 0.13% 110
2024
Q2
$41.1M Buy
260,235
+10,768
+4% +$1.87M 0.14% 96
2024
Q1
$49.4M Sell
249,467
-40,661
-14% -$7.43M 0.18% 80
2023
Q4
$50.5M Buy
290,128
+45,474
+19% +$7.21M 0.22% 80
2023
Q3
$38.3M Sell
244,654
-47,185
-16% -$7.81M 0.18% 101
2023
Q2
$47.9M Buy
291,839
+92,811
+47% +$13.6M 0.22% 78
2023
Q1
$30.7M Sell
199,028
-114,500
-37% -$18.2M 0.16% 137
2022
Q4
$41.3M Buy
313,528
+100,526
+47% +$13.7M 0.22% 86
2022
Q3
$22.8M Buy
213,002
+900
+0.4% +$113K 0.13% 176
2022
Q2
$22.1M Buy
212,102
+157,439
+288% +$21.3M 0.12% 184
2022
Q1
$8.13M Buy
54,663
+23,987
+78% +$2.94M 0.04% 290
2021
Q4
$3.5M Buy
30,676
+109
+0.4% +$11.9K 0.02% 384
2021
Q3
$3.01M Sell
30,567
-6,200
-17% -$659K 0.01% 409
2021
Q2
$3.53M Sell
36,767
-3,600
-9% -$337K 0.02% 386
2021
Q1
$3.24M Buy
40,367
+16,800
+71% +$1.02M 0.02% 398
2020
Q4
$1.25M Buy
+23,567
New +$1.22M 0.01% 531
2019
Q3
Sell
-64,400
Closed -$3.55M 770
2019
Q2
$3.55M Buy
64,400
+300
+0.5% +$16.5K 0.03% 352
2019
Q1
$3.74M Sell
64,100
-12,300
-16% -$721K 0.03% 316
2018
Q4
$3.96M Buy
+76,400
New +$4.52M 0.03% 212
2017
Q3
Sell
-68,900
Closed -$3.99M 609
2017
Q2
$3.99M Buy
68,900
+32,500
+89% +$1.91M 0.02% 262
2017
Q1
$2.17M Buy
+36,400
New +$2.22M 0.01% 315

Other funds holding NUE

Grantham, Mayo, Van Otterloo & Co (GMO)'s NUE Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Nucor (NUE) stake by 5.8% in Q1 2026, buying an estimated $2.45M and bringing the position to 257,987 shares worth $43.6M. The position accounts for 0.11% of the portfolio, ranked #80.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NUE in Q1 2017 and has held it in 27 quarters since. The position peaked at $50.5M in Q4 2023. 1,370 funds tracked by Wall St. Rank hold NUE as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 257,987 shares of Nucor worth $43.6M as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 14,050 Nucor shares in Q1 2026, an estimated $2.45M.
  • Nucor made up 0.11% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #80 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Nucor in Q1 2017 and has held it in 27 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Nucor position peaked at $50.5M in Q4 2023.
  • 1,370 funds tracked by Wall St. Rank held Nucor as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.